Biocon Limited (NSE:BIOCON)

Biocon Revenue

Biocon had revenue of 43.89B INR in the quarter ending September 30, 2026, with 2.17% growth. This brings the company's total for the last twelve months to 174.15B, up 5.70% year-over-year. In the fiscal year ending March 31, 2026, Biocon had annual revenue of 169.27B with 10.91% growth. That makes Biocon the 5,228th largest company in the world by revenue and 174th in India.

• Revenue (ttm): 174.15B
• Revenue Growth: +5.70%
• P/S Ratio: 3.47
• Revenue / Employee: 10.59M
• Employees: 16,447
• Market Cap: 604.02B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biosimilars 104.31B 60.2%
• Services 37.39B 21.6%
• Generics 31.68B 18.3%

By Geography

Chart

• United States of America 79.95B 47.2%
• European Union (Including Ireland) 46.17B 27.3%
• Rest of The World 33.98B 20.1%
• India 9.18B 5.4%

Fiscal year ended Mar 31, 2026 See the full Biocon breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	169.27B	16.65B	10.91%
Mar 31, 2025	152.62B	5.06B	3.43%
Mar 31, 2024	147.56B	35.82B	32.05%
Mar 31, 2023	111.74B	29.90B	36.54%
Mar 31, 2022	81.84B	10.41B	14.57%

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error